Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SRRM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CAMK2N1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPNE4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFAF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZBTB21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOSL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC339622 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPCN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAT8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESYT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRG1BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DENND4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DVL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST3GAL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on